(+)-catechin multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of SLC22A5 mRNA CTD PMID:24763279 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC22A5 mRNA] CTD PMID:31150632 (R)-carnitine multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 [Doxorubicin co-treated with Carnitine] results in increased expression of SLC22A5 mRNA more ... CTD PMID:16283381 more ... (R)-carnitine multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Carnitine inhibits the reaction [SLC22A5 protein results in increased abundance of and results in increased localization of Doxorubicin] CTD PMID:37453608 (R)-carnitine decreases expression ISO Slc22a5 (Mus musculus) 6480464 Carnitine results in decreased expression of SLC22A5 mRNA and Carnitine results in decreased expression of SLC22A5 protein CTD PMID:30465787 (R)-carnitine decreases expression ISO SLC22A5 (Homo sapiens) 6480464 Carnitine results in decreased expression of SLC22A5 mRNA and Carnitine results in decreased expression of SLC22A5 protein CTD PMID:30465787 (R)-carnitine increases transport EXP 6480464 SLC22A5 protein results in increased transport of Carnitine CTD PMID:19041296 (R)-carnitine affects binding ISO SLC22A5 (Homo sapiens) 6480464 Carnitine binds to SLC22A5 protein CTD PMID:19539806 (R)-carnitine affects uptake ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein affects the uptake of Carnitine CTD PMID:15486076 (R)-carnitine multiple interactions EXP 6480464 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] more ... CTD PMID:12644265 more ... (R)-carnitine increases expression EXP 6480464 Carnitine deficiency results in increased expression of SLC22A5 mRNA CTD PMID:20303936 (R)-carnitine increases uptake EXP 6480464 SLC22A5 protein results in increased uptake of Carnitine CTD PMID:12644265 more ... (R)-carnitine increases transport ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased transport of Carnitine CTD PMID:19539806 (R)-carnitine increases uptake ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased uptake of Carnitine and SLC22A5 protein results in increased uptake of Carnitine analog CTD PMID:16928358 more ... 1,1-dichloroethene decreases expression ISO Slc22a5 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC22A5 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO Slc22a5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC22A5 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SLC22A5 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO Slc22a5 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of SLC22A5 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO SLC22A5 (Homo sapiens) 6480464 Estradiol results in increased expression of SLC22A5 mRNA CTD PMID:15223131 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of SLC22A5 mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc22a5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC22A5 mRNA CTD PMID:16120747 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC22A5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO SLC22A5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC22A5 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc22a5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC22A5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC22A5 mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of SLC22A5 mRNA CTD PMID:21346803 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO SLC22A5 (Homo sapiens) 6480464 Verapamil results in decreased activity of SLC22A5 protein CTD PMID:15486076 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Slc22a5 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of SLC22A5 mRNA CTD PMID:19162173 5-aza-2'-deoxycytidine increases expression ISO SLC22A5 (Homo sapiens) 6480464 Decitabine results in increased expression of SLC22A5 mRNA CTD PMID:28597291 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 Dithioerythritol inhibits the reaction [Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine]] and Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine] CTD PMID:19041296 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SLC22A5 mRNA CTD PMID:28959563 afimoxifene multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of SLC22A5 mRNA] CTD PMID:21233418 aflatoxin B1 increases expression ISO Slc22a5 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of SLC22A5 mRNA CTD PMID:19770486 aflatoxin B1 increases mutagenesis EXP 6480464 Aflatoxin B1 results in increased mutagenesis of SLC22A5 gene CTD PMID:36908029 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SLC22A5 mRNA CTD PMID:33354967 all-trans-retinoic acid increases expression ISO SLC22A5 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC22A5 mRNA CTD PMID:21934132 allopurinol multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Fructose results in decreased expression of SLC22A5 protein] CTD PMID:22426011 allopurinol multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Allopurinol inhibits the reaction [potassium oxonate results in decreased expression of SLC22A5 mRNA] and Allopurinol inhibits the reaction [potassium oxonate results in decreased expression of SLC22A5 protein] CTD PMID:21909718 and PMID:22865646 amiodarone multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Amiodarone inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:21641380 amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of SLC22A5 mRNA CTD PMID:32084307 angelicin increases expression ISO Slc22a5 (Mus musculus) 6480464 angelicin results in increased expression of SLC22A5 protein CTD PMID:22173200 antirheumatic drug increases expression ISO SLC22A5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of SLC22A5 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO SLC22A5 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of SLC22A5 mRNA CTD PMID:33212167 aristolochic acids decreases expression EXP 6480464 Aristolochic Acids results in decreased expression of SLC22A5 mRNA and Aristolochic Acids results in decreased expression of SLC22A5 protein CTD PMID:21167265 arsane affects expression ISO SLC22A5 (Homo sapiens) 6480464 Arsenic affects the expression of SLC22A5 mRNA CTD PMID:30746931 arsane increases methylation ISO SLC22A5 (Homo sapiens) 6480464 Arsenic results in increased methylation of SLC22A5 gene CTD PMID:30746931 arsenic atom increases methylation ISO SLC22A5 (Homo sapiens) 6480464 Arsenic results in increased methylation of SLC22A5 gene CTD PMID:30746931 arsenic atom affects expression ISO SLC22A5 (Homo sapiens) 6480464 Arsenic affects the expression of SLC22A5 mRNA CTD PMID:30746931 arsenous acid decreases response to substance ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 atorvastatin calcium multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Atorvastatin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:21641380 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC22A5 gene CTD PMID:28931070 benzo[a]pyrene increases expression ISO Slc22a5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC22A5 mRNA CTD PMID:19770486 bis(2-chloroethyl) sulfide increases expression ISO Slc22a5 (Mus musculus) 6480464 Mustard Gas results in increased expression of SLC22A5 mRNA CTD PMID:15674844 bisphenol A decreases expression ISO Slc22a5 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC22A5 mRNA CTD PMID:21932408 bisphenol A increases expression ISO Slc22a5 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC22A5 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC22A5 mRNA CTD PMID:25181051 more ... bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of SLC22A5 mRNA CTD PMID:32479839 buta-1,3-diene increases expression ISO Slc22a5 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of SLC22A5 mRNA CTD PMID:29038090 cadmium atom multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC22A5 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC22A5 mRNA CTD PMID:35301059 CAR(3:0(Me2)) increases uptake ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased uptake of pivaloylcarnitine CTD PMID:18762717 CAR(3:0(Me2)) increases uptake EXP 6480464 SLC22A5 protein results in increased uptake of pivaloylcarnitine CTD PMID:18762717 CAR(3:0(Me2)) multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Carnitine inhibits the reaction [SLC22A5 protein results in increased transport of pivaloylcarnitine] and pivaloylcarnitine inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine] CTD PMID:19539806 CAR(3:0(Me2)) affects binding ISO SLC22A5 (Homo sapiens) 6480464 pivaloylcarnitine binds to SLC22A5 protein CTD PMID:19539806 CAR(3:0(Me2)) increases transport ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased transport of pivaloylcarnitine CTD PMID:19539806 carbamazepine decreases expression ISO SLC22A5 (Homo sapiens) 6480464 Carbamazepine results in decreased expression of SLC22A5 mRNA CTD PMID:17112801 carbon nanotube increases expression ISO Slc22a5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 carebastine multiple interactions ISO Slc22a5 (Mus musculus) 6480464 carebastine inhibits the reaction [SLC22A5 gene mutant form affects the transport of and affects the abundance of Pyrilamine] CTD PMID:19821448 carmustine affects response to substance ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of SLC22A5 mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC22A5 gene] CTD PMID:28238834 choline multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Choline inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:16928358 ciguatoxin CTX1B affects expression ISO Slc22a5 (Mus musculus) 6480464 Ciguatoxins affects the expression of SLC22A5 mRNA CTD PMID:18353800 cisplatin decreases expression ISO SLC22A5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of SLC22A5 mRNA and Cisplatin results in decreased expression of SLC22A5 protein CTD PMID:19736245 and PMID:27392435 cisplatin multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SLC22A5 mRNA CTD PMID:27392435 clofibrate increases expression ISO Slc22a5 (Mus musculus) 6480464 Clofibrate results in increased expression of SLC22A5 mRNA CTD PMID:23811191 and PMID:30629241 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of SLC22A5 mRNA CTD PMID:27665778 more ... clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC22A5 mRNA CTD PMID:17602206 clozapine multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Clozapine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:30465787 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC22A5 mRNA CTD PMID:26577399 cyclophosphamide multiple interactions EXP 6480464 Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of SLC22A5 mRNA] and Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of SLC22A5 protein] CTD PMID:22701146 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of SLC22A5 mRNA and Cyclophosphamide results in decreased expression of SLC22A5 protein CTD PMID:22701146 cyclosporin A increases expression ISO SLC22A5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC22A5 mRNA CTD PMID:20106945 cyproheptadine multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Cyproheptadine affects the reaction [SLC22A5 gene mutant form affects the transport of and affects the abundance of Pyrilamine] CTD PMID:19821448 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC22A5 mRNA CTD PMID:23640034 dextran sulfate multiple interactions ISO Slc22a5 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC22A5 mRNA CTD PMID:29950665 diarsenic trioxide decreases response to substance ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dichloroacetic acid increases expression ISO Slc22a5 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of SLC22A5 mRNA CTD PMID:28962523 diphenhydramine multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Diphenhydramine affects the reaction [SLC22A5 gene mutant form affects the transport of and affects the abundance of Pyrilamine] and Diphenhydramine inhibits the reaction [SLC22A5 gene mutant form affects the transport of and affects the abundance of Pyrilamine] CTD PMID:19821448 dithioerythritol multiple interactions EXP 6480464 Dithioerythritol inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein] more ... CTD PMID:19041296 and PMID:22900493 doxorubicin multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 [Doxorubicin co-treated with Carnitine] results in increased expression of SLC22A5 mRNA more ... CTD PMID:16283381 and PMID:37453608 doxorubicin increases abundance ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased abundance of Doxorubicin CTD PMID:37453608 doxorubicin multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Carnitine inhibits the reaction [SLC22A5 protein results in increased abundance of and results in increased localization of Doxorubicin] and SLC22A5 protein results in increased abundance of and results in increased localization of Doxorubicin CTD PMID:37453608 doxorubicin decreases expression ISO SLC22A5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SLC22A5 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 Carnitine inhibits the reaction [Doxorubicin results in decreased expression of SLC22A5 mRNA] CTD PMID:20470772 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of SLC22A5 mRNA CTD PMID:20470772 dronedarone affects response to substance ISO Slc22a5 (Mus musculus) 6480464 SLC22A5 protein affects the susceptibility to dronedarone CTD PMID:24881592 Ebastine multiple interactions ISO Slc22a5 (Mus musculus) 6480464 ebastine inhibits the reaction [SLC22A5 gene mutant form affects the transport of and affects the abundance of Pyrilamine] CTD PMID:19821448 enilconazole decreases expression ISO SLC22A5 (Homo sapiens) 6480464 enilconazole results in decreased expression of SLC22A5 mRNA and enilconazole results in decreased expression of SLC22A5 protein CTD PMID:36150497 enilconazole decreases expression ISO Slc22a5 (Mus musculus) 6480464 enilconazole results in decreased expression of SLC22A5 mRNA and enilconazole results in decreased expression of SLC22A5 protein CTD PMID:36150497 ethyl methanesulfonate increases expression ISO SLC22A5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of SLC22A5 mRNA CTD PMID:23649840 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of SLC22A5 mRNA CTD PMID:27665778 and PMID:32741897 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of SLC22A5 mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC22A5 mRNA CTD PMID:24136188 folic acid decreases expression ISO Slc22a5 (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC22A5 mRNA CTD PMID:25629700 fructose decreases expression EXP 6480464 Fructose results in decreased expression of SLC22A5 protein CTD PMID:22426011 fructose multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Fructose results in decreased expression of SLC22A5 protein] and Quercetin inhibits the reaction [Fructose results in decreased expression of SLC22A5 protein] CTD PMID:22426011 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of SLC22A5 mRNA CTD PMID:27665778 genistein increases expression ISO SLC22A5 (Homo sapiens) 6480464 Genistein results in increased expression of SLC22A5 mRNA CTD PMID:23019147 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC22A5 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SLC22A5 mRNA CTD PMID:24136188 glycine betaine multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Betaine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:16928358 graphite affects expression EXP 6480464 Graphite affects the expression of SLC22A5 mRNA CTD PMID:29933104 Grepafloxacin multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 grepafloxacin affects the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:16928358 hydroxyurea increases uptake ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased uptake of Hydroxyurea CTD PMID:21256917 ifosfamide decreases expression EXP 6480464 Ifosfamide results in decreased expression of SLC22A5 mRNA and Ifosfamide results in decreased expression of SLC22A5 protein CTD PMID:22701146 imperatorin increases expression ISO Slc22a5 (Mus musculus) 6480464 imperatorin results in increased expression of SLC22A5 protein CTD PMID:22173200 inulin multiple interactions ISO Slc22a5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC22A5 mRNA CTD PMID:36331819 ipratropium multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Ipratropium inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:21641380 isoimperatorin increases expression ISO Slc22a5 (Mus musculus) 6480464 isoimperatorin results in increased expression of SLC22A5 protein CTD PMID:22173200 L-cysteine multiple interactions EXP 6480464 Cysteine inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein] and Cysteine inhibits the reaction [Methylmercury Compounds results in decreased transport of SLC22A5 protein] CTD PMID:22900493 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of SLC22A5 mRNA CTD PMID:24136188 lenvatinib decreases expression ISO Slc22a5 (Mus musculus) 6480464 lenvatinib results in decreased expression of SLC22A5 protein CTD PMID:35788046 lenvatinib decreases expression EXP 6480464 lenvatinib results in decreased expression of SLC22A5 mRNA and lenvatinib results in decreased expression of SLC22A5 protein CTD PMID:35788046 lidocaine multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Lidocaine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:21641380 mangiferin increases expression ISO Slc22a5 (Mus musculus) 6480464 mangiferin results in increased expression of SLC22A5 mRNA CTD PMID:21348301 meldonium increases uptake EXP 6480464 SLC22A5 protein results in increased uptake of 3-(2 more ... CTD PMID:18981167 meldonium increases uptake ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased uptake of 3-(2 more ... CTD PMID:18981167 mepyramine multiple interactions ISO Slc22a5 (Mus musculus) 6480464 carebastine inhibits the reaction [SLC22A5 gene mutant form affects the transport of and affects the abundance of Pyrilamine] more ... CTD PMID:19821448 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of SLC22A5 mRNA CTD PMID:16507785 mercury dichloride decreases transport EXP 6480464 Mercuric Chloride results in decreased transport of SLC22A5 protein CTD PMID:22900493 mercury dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein] more ... CTD PMID:22900493 metformin increases expression EXP 6480464 Metformin results in increased expression of SLC22A5 mRNA CTD PMID:31324951 metformin multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Metformin inhibits the reaction [SLC22A5 protein results in increased abundance of Doxorubicin] CTD PMID:37453608 methoxsalen increases expression ISO Slc22a5 (Mus musculus) 6480464 Methoxsalen results in increased expression of SLC22A5 protein CTD PMID:22173200 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SLC22A5 gene CTD PMID:35440735 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of SLC22A5 mRNA CTD PMID:21515302 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine affects the reaction [Methylmercury Compounds results in decreased transport of SLC22A5 protein] and Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein] CTD PMID:22900493 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] and 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A5 protein results in increased uptake of Tetraethylammonium] CTD PMID:12644265 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC22A5 mRNA CTD PMID:17602206 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SLC22A5 mRNA CTD PMID:24136188 nifedipine multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Nifedipine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:21641380 ofloxacin multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Ofloxacin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:16928358 ofloxacin multiple interactions EXP 6480464 Ofloxacin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:16928358 olanzapine decreases expression ISO Slc22a5 (Mus musculus) 6480464 Olanzapine results in decreased expression of SLC22A5 mRNA and Olanzapine results in decreased expression of SLC22A5 protein CTD PMID:31437515 olanzapine multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Olanzapine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine analog] CTD PMID:31437515 omeprazole multiple interactions EXP 6480464 Dithioerythritol inhibits the reaction [Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine]] and Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine] CTD PMID:19041296 oxaliplatin increases response to substance ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased susceptibility to Oxaliplatin CTD PMID:34252480 oxaliplatin multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 tetrahydropalmatine inhibits the reaction [SLC22A5 protein results in increased import of Oxaliplatin] CTD PMID:34252480 oxaliplatin increases import ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 protein results in increased import of Oxaliplatin CTD PMID:34252480 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of SLC22A5 mRNA CTD PMID:23439660 ozone multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC22A5 mRNA CTD PMID:35430440 paracetamol affects expression ISO Slc22a5 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC22A5 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC22A5 mRNA CTD PMID:33387578 pentachlorophenol increases expression ISO Slc22a5 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of SLC22A5 mRNA CTD PMID:23892564 perfluorohexanesulfonic acid increases expression ISO Slc22a5 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of SLC22A5 mRNA CTD PMID:28558994 perfluorononanoic acid increases expression ISO Slc22a5 (Mus musculus) 6480464 perfluoro-n-nonanoic acid results in increased expression of SLC22A5 mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid increases expression ISO Slc22a5 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of SLC22A5 mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc22a5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC22A5 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of SLC22A5 mRNA CTD PMID:16221955 more ... perfluorooctanoic acid increases expression ISO Slc22a5 (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of SLC22A5 mRNA CTD PMID:28558994 and PMID:30711707 permethrin increases expression ISO Slc22a5 (Mus musculus) 6480464 Permethrin results in increased expression of SLC22A5 mRNA CTD PMID:30629241 phenformin increases expression EXP 6480464 Phenformin results in increased expression of SLC22A5 mRNA CTD PMID:31324951 phenobarbital increases expression ISO Slc22a5 (Mus musculus) 6480464 Phenobarbital results in increased expression of SLC22A5 mRNA CTD PMID:19270015 pirinixic acid multiple interactions ISO Slc22a5 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC22A5 mRNA more ... CTD PMID:18489776 more ... pirinixic acid increases expression ISO Slc22a5 (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC22A5 mRNA CTD PMID:17426115 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC22A5 mRNA CTD PMID:19162173 more ... pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC22A5 mRNA CTD PMID:19735737 Potassium 2,6-dihydroxytriazinecarboxylate multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Allopurinol inhibits the reaction [potassium oxonate results in decreased expression of SLC22A5 mRNA] more ... CTD PMID:21909718 more ... Potassium 2,6-dihydroxytriazinecarboxylate decreases expression ISO Slc22a5 (Mus musculus) 6480464 potassium oxonate results in decreased expression of SLC22A5 mRNA and potassium oxonate results in decreased expression of SLC22A5 protein CTD PMID:21909718 more ... pravastatin affects expression EXP 6480464 Pravastatin affects the expression of SLC22A5 mRNA CTD PMID:27225895 pravastatin decreases expression ISO Slc22a5 (Mus musculus) 6480464 Pravastatin results in decreased expression of SLC22A5 mRNA CTD PMID:27225895 probenecid multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Probenecid inhibits the reaction [potassium oxonate results in decreased expression of SLC22A5 mRNA] and Probenecid inhibits the reaction [potassium oxonate results in decreased expression of SLC22A5 protein] CTD PMID:22865646 and PMID:22967667 progesterone increases expression ISO SLC22A5 (Homo sapiens) 6480464 Progesterone results in increased expression of SLC22A5 mRNA CTD PMID:21540246 promethazine multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Promethazine affects the reaction [SLC22A5 gene mutant form affects the transport of and affects the abundance of Pyrilamine] and Promethazine inhibits the reaction [SLC22A5 gene mutant form affects the transport of and affects the abundance of Pyrilamine] CTD PMID:19821448 propiconazole increases expression ISO Slc22a5 (Mus musculus) 6480464 propiconazole results in increased expression of SLC22A5 mRNA CTD PMID:21278054 propranolol multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Propranolol inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:21641380 psoralen increases expression ISO Slc22a5 (Mus musculus) 6480464 Ficusin results in increased expression of SLC22A5 protein CTD PMID:22173200 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Fructose results in decreased expression of SLC22A5 protein] CTD PMID:22426011 quercetin multiple interactions ISO Slc22a5 (Mus musculus) 6480464 Quercetin inhibits the reaction [potassium oxonate results in decreased expression of SLC22A5 mRNA] and Quercetin inhibits the reaction [potassium oxonate results in decreased expression of SLC22A5 protein] CTD PMID:21909718 quercetin decreases expression ISO SLC22A5 (Homo sapiens) 6480464 Quercetin results in decreased expression of SLC22A5 mRNA CTD PMID:21632981 quetiapine fumarate multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Quetiapine Fumarate inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:30465787 raloxifene affects expression ISO SLC22A5 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of SLC22A5 mRNA CTD PMID:14699072 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC22A5 mRNA CTD PMID:28374803 spironolactone multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 Spironolactone inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:21641380 sunitinib decreases expression ISO SLC22A5 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SLC22A5 mRNA CTD PMID:31533062 talinolol multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 talinolol inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:21641380 tamoxifen affects expression ISO Slc22a5 (Mus musculus) 6480464 Tamoxifen affects the expression of SLC22A5 mRNA CTD PMID:17555576 temozolomide affects response to substance ISO SLC22A5 (Homo sapiens) 6480464 SLC22A5 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of SLC22A5 mRNA CTD PMID:21515302 tetrachloroethene increases expression ISO Slc22a5 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of SLC22A5 mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC22A5 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC22A5 mRNA] CTD PMID:31150632 tetraethylammonium multiple interactions EXP 6480464 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A5 protein results in increased uptake of Tetraethylammonium] more ... CTD PMID:12644265 tetraethylammonium increases uptake EXP 6480464 SLC22A5 protein results in increased uptake of Tetraethylammonium CTD PMID:12644265 tetrahydropalmatine multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 tetrahydropalmatine inhibits the reaction [SLC22A5 protein results in increased import of Oxaliplatin] CTD PMID:34252480 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC22A5 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO Slc22a5 (Mus musculus) 6480464 titanium dioxide affects the expression of SLC22A5 mRNA CTD PMID:17656681 titanium dioxide multiple interactions ISO Slc22a5 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC22A5 mRNA CTD PMID:29950665 toluene affects expression EXP 6480464 Toluene affects the expression of SLC22A5 mRNA CTD PMID:18653662 trans-piceid multiple interactions ISO Slc22a5 (Mus musculus) 6480464 polydatin inhibits the reaction [potassium oxonate results in decreased expression of SLC22A5 protein] CTD PMID:22865646 trichloroethene affects expression ISO Slc22a5 (Mus musculus) 6480464 Trichloroethylene affects the expression of SLC22A5 mRNA CTD PMID:21135412 trichloroethene increases expression ISO Slc22a5 (Mus musculus) 6480464 Trichloroethylene results in increased expression of SLC22A5 mRNA CTD PMID:25549359 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of SLC22A5 mRNA CTD PMID:21515302 troglitazone increases expression ISO Slc22a5 (Mus musculus) 6480464 troglitazone results in increased expression of SLC22A5 mRNA CTD PMID:28973697 tunicamycin increases expression ISO SLC22A5 (Homo sapiens) 6480464 Tunicamycin results in increased expression of SLC22A5 mRNA CTD PMID:29453283 urethane decreases expression ISO SLC22A5 (Homo sapiens) 6480464 Urethane results in decreased expression of SLC22A5 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of SLC22A5 mRNA CTD PMID:24136188 valproic acid affects expression ISO Slc22a5 (Mus musculus) 6480464 Valproic Acid affects the expression of SLC22A5 mRNA CTD PMID:17292431 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SLC22A5 mRNA CTD PMID:32437819 valproic acid decreases methylation ISO SLC22A5 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of SLC22A5 gene CTD PMID:29154799 vancomycin increases expression ISO Slc22a5 (Mus musculus) 6480464 Vancomycin results in increased expression of SLC22A5 mRNA CTD PMID:18930951 verapamil decreases activity ISO SLC22A5 (Homo sapiens) 6480464 Verapamil results in decreased activity of SLC22A5 protein CTD PMID:15486076 vorinostat decreases expression ISO SLC22A5 (Homo sapiens) 6480464 vorinostat results in decreased expression of SLC22A5 mRNA CTD PMID:27188386 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of SLC22A5 mRNA CTD PMID:27225895 zaragozic acid A increases expression ISO Slc22a5 (Mus musculus) 6480464 squalestatin 1 results in increased expression of SLC22A5 mRNA CTD PMID:27225895 zidovudine increases expression ISO SLC22A5 (Homo sapiens) 6480464 Zidovudine results in increased expression of SLC22A5 mRNA CTD PMID:24292225 ziprasidone multiple interactions ISO SLC22A5 (Homo sapiens) 6480464 ziprasidone inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] CTD PMID:30465787